4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs

Details 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs

2011-08-30

2011-08-30

Saeed, Kamal (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C562S431000

Reexamination Certificate

active

08008513

ABSTRACT:
The invention features 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, compositions containing them, and methods of using them as PPAR delta modulators to treat or inhibit the progression of, for example, dyslipidemia.

REFERENCES:
patent: 4125732 (1978-11-01), McEvoy et al.
patent: 4820867 (1989-04-01), Belanger et al.
patent: 5726165 (1998-03-01), Beeley et al.
patent: 7301050 (2007-11-01), Kuo et al.
patent: 7425649 (2008-09-01), Kuo et al.
patent: 7598416 (2009-10-01), Kuo et al.
patent: 7635718 (2009-12-01), Kuo et al.
patent: 2006/0058393 (2006-03-01), DeAngelis et al.
patent: 2006/0257987 (2006-11-01), Gonzalez
patent: 2007/0060649 (2007-03-01), Abdel-Magid et al.
patent: 2009/0318332 (2009-12-01), Kuo et al.
patent: 0056172 (1982-07-01), None
patent: 0092136 (1983-10-01), None
patent: 0106565 (1984-04-01), None
patent: 61-268651 (1986-11-01), None
patent: 97/27847 (1997-08-01), None
patent: WO 03/011807 (2003-02-01), None
patent: WO 03/074495 (2003-09-01), None
patent: 2005/019151 (2005-03-01), None
Auboeuf et al., “Tissue Distribution and Quantification of the Expression of mRNAs of Peroxisome Proliferator-Activated Receptors and Liver X Receptor-α in Humans.”, Diabetes, 1997, vol. 46, pp. 1319-1327.
Berge et al., “Pharmaceutical Salts.”, J. Pharm.Sci., 1977, vol. 66(1), pp. 1-19.
Boden, G., “Free Fatty Acids, Insulin Resistance, and Type 2 Diabetes Mellitus.”, Proceedings of the Association of American Physicians, 1991, vol. 111(3), pp. 241-248.
Braissant et al., “Differential Expression of Peroxisome Proliferator-Activated Receptors (PPARs): Tissue Distribution of PPAR-α, -β, and -γ in the Adult Rat*.”, Endrocrinology, 1996, vol. 137(1), pp. 354-366.
Lawn et al., “The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway.”, J. Clin. Investigation, 1999, vol. 104(8), pp. R25-R31.
Leibowitz et al., “Activation of PPARδ alters lipin metabolism in db/db mice.”, FEBS Lett., 2000, vol. 473(3), pp. 333-336.
Oliver et al., “A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport.”, PNAS, 2001, vol. 98(9), pp. 5306-5311, USA.
Shi et al., “The peroxisome proliferator-activated receptor ,an integrator of transcriptional repression and nuclear receptor signaling.”, Proc Natl. Acad. Sci., 2002, vol. 99(5), pp. 2613-2618, USA.
Sznaidman et al., “Novel Selective Small Molecule Agonists for Peroxisome Proliferator-Activated Receptor δ (PPARδ)-Synthesis and Biological Activity.”, Bioorganic & Medicinal Chemistry Letters, 2003, vol. 13. pp. 1517-1521.
International Search Report , International Application No. PCT/US2004/030188, Date of Mailing of International Search Report, Mar. 4, 2005.
Written Opinion, International Application No. PCT/US2004/030188.
Richard B. Silverman, The Organic Chemistry of Drug Design and Drug Action, 1992, pp. 15-20.

Affiliated with

Also associated with

Rating

4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2793621